Prospective Observational Association Between SLCO1B1 Gene Polymorphism and the Anti-factor Xa Activity of Edoxaban in Patients With Moderate to Severe Renal Insufficiency

Dose-finding of Rivaroxaban in Hemodialysis

NCT02047006 ·Status: COMPLETED ·Phase: PHASE4

Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy

NCT05136456 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Ravulizumab in Chinese Adults Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT06578949 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Pharmacokinetics of GSK1278863 in Subjects With End Stage Renal Disease Undergoing Peritoneal Dialysis

NCT02243306 ·Status: COMPLETED ·Phase: PHASE1

Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

NCT04344769 ·Status: RECRUITING

Open-label, Multiple Ascending Dose Study of Ravulizumab (ALXN1210) in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT02605993 ·Status: COMPLETED ·Phase: PHASE2

Assessment of the Pharmacokinetics of GSK1278863 and Metabolites in Normal Subjects and Subjects With Renal Impairment

NCT01406340 ·Status: TERMINATED ·Phase: PHASE1

Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function

NCT06496217 ·Status: COMPLETED ·Phase: PHASE1

16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis

NCT02260193 ·Status: COMPLETED ·Phase: PHASE2

42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia

NCT01381094 ·Status: COMPLETED ·Phase: PHASE2

Study of Pirtobrutinib (LOXO-305) in Participants With Impaired Kidney Function and Healthy Participants

NCT06190678 ·Status: COMPLETED ·Phase: PHASE1

Multiple Dose Study of the Safety, Tolerability, Pharmacokinetics and Effect on Renal Potassium Clearance

NCT01237899 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of the Pharmacokinetics and Safety of Inaxaplin in Participants With Mild or Moderate Hepatic Impairment

NCT06529796 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of Dabrafenib in Subjects With Renal Impairment

NCT02852239 ·Status: COMPLETED ·Phase: PHASE1

Study of the Oral Factor D (FD) Inhibitor ALXN2050 in PNH Patients as Monotherapy

NCT04170023 ·Status: TERMINATED ·Phase: PHASE2

Pharmacokinetic Study of Fondaparinux in Outpatients With Renal Dysfunction

NCT00483600 ·Status: WITHDRAWN ·Phase: NA

A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis

NCT01750190 ·Status: COMPLETED ·Phase: PHASE3

20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia

NCT01906489 ·Status: COMPLETED ·Phase: PHASE2

PK//PD/Tolerability Study of DA-1229(Evogliptin) in Renal Impaired Patients

NCT02214693 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease.

NCT01711853 ·Status: COMPLETED ·Phase: PHASE1

A Multi-Center, Open-Label Study

NCT01468259 ·Status: WITHDRAWN ·Phase: PHASE1

Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia

NCT01235936 ·Status: COMPLETED ·Phase: PHASE2

PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function

NCT04656795 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis

NCT02174627 ·Status: COMPLETED ·Phase: PHASE3

Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted

NCT03832114 ·Status: COMPLETED ·Phase: PHASE2